• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用肽核酸(PNA)-DNA 探针对 EGFR 突变癌细胞进行成像分析。

Imaging analysis of EGFR mutated cancer cells using peptide nucleic acid (PNA)-DNA probes.

机构信息

Health Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.

Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, 3-1-1 Tsushimanaka, Okayama 700-8530, Japan.

出版信息

Analyst. 2019 Aug 7;144(15):4613-4621. doi: 10.1039/c9an00725c. Epub 2019 Jun 26.

DOI:10.1039/c9an00725c
PMID:31241068
Abstract

Lung cancer cells harbor various gene mutations in the mRNA sequence of the Epidermal Growth Factor Receptor (EGFR), especially the mutations of exon19del E746-A750, T790M, and L858R. This results in cancer progression and resistance to anticancer drugs (tyrosine kinase inhibitor; TKI). Therefore, the imaging analysis of EGFR mutations is required for the treatment planning for non-small cell lung cancers. This study focused on the imaging analysis of a single nucleotide substitute in EGFR mutated cancer cells. We developed three novel peptide nucleic acid (PNA)-DNA probes for recognizing and detecting the following three gene mutations in EGFR gene mutations. The PNA-DNA probes consist of fluorescein isothiocyanate (FITC) conjugated PNA as a detection probe and Dabcyl conjugated DNA as a quencher probe. The PNA-DNA probes were used to validate the feasibility for detecting three EGFR mutated sequences: exon19del E746-A750, T790M, and L858R. The three probes emitted fluorescent dose-dependent signals against three target DNA and RNA. Using the three PNA-DNA probes, we succeeded in distinguishing three kinds of lung-cancer cell lines (H1975, PC-9, and A549) which have different EGFR mutations by the fluorescence in situ hybridization (FISH) method.

摘要

肺癌细胞在表皮生长因子受体 (EGFR) 的 mRNA 序列中存在各种基因突变,特别是外显子 19del E746-A750、T790M 和 L858R 的突变。这导致癌症的进展和对抗癌药物(酪氨酸激酶抑制剂;TKI)的耐药性。因此,需要对 EGFR 突变进行成像分析,以制定非小细胞肺癌的治疗计划。本研究集中于 EGFR 突变癌细胞中单核苷酸替代的成像分析。我们开发了三种新型肽核酸(PNA)-DNA 探针,用于识别和检测 EGFR 基因突变中的以下三种基因突变。PNA-DNA 探针由荧光素异硫氰酸酯(FITC)缀合的 PNA 作为检测探针和 Dabcyl 缀合的 DNA 作为淬灭探针组成。PNA-DNA 探针用于验证检测三种 EGFR 突变序列:外显子 19del E746-A750、T790M 和 L858R 的可行性。三种探针针对三种靶 DNA 和 RNA 发出荧光剂量依赖性信号。使用这三种 PNA-DNA 探针,我们成功地通过荧光原位杂交(FISH)方法区分了具有不同 EGFR 突变的三种肺癌细胞系(H1975、PC-9 和 A549)。

相似文献

1
Imaging analysis of EGFR mutated cancer cells using peptide nucleic acid (PNA)-DNA probes.使用肽核酸(PNA)-DNA 探针对 EGFR 突变癌细胞进行成像分析。
Analyst. 2019 Aug 7;144(15):4613-4621. doi: 10.1039/c9an00725c. Epub 2019 Jun 26.
2
Localization of Mutations in Non-small-cell Lung Cancer Tissues Using Mutation-specific PNA-DNA Probes.使用突变特异性 PNA-DNA 探针定位非小细胞肺癌组织中的突变。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):375-382. doi: 10.21873/cgp.20389.
3
Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.利用胸腔积液样本和肽核酸探针检测法预测非小细胞肺癌患者表皮生长因子受体靶向治疗的疗效
Clin Chem Lab Med. 2017 Oct 26;55(12):1979-1986. doi: 10.1515/cclm-2016-0809.
4
Analysis of Single Nucleotide-Mutated Single-Cancer Cells Using the Combined Technologies of Single-Cell Microarray Chips and Peptide Nucleic Acid-DNA Probes.利用单细胞微阵列芯片和肽核酸-DNA探针联合技术分析单核苷酸突变的单癌细胞
Micromachines (Basel). 2020 Jun 27;11(7):628. doi: 10.3390/mi11070628.
5
Biotinylated probe isolation of targeted gene region improves detection of T790M epidermal growth factor receptor mutation via peptide nucleic acid-enriched real-time PCR.生物素标记探针靶向基因区域分离提高了肽核酸富集实时 PCR 检测 T790M 表皮生长因子受体突变。
Clin Chem. 2011 May;57(5):770-3. doi: 10.1373/clinchem.2010.157784. Epub 2011 Feb 16.
6
Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.肽核酸钳夹法与直接测序法在非小细胞肺癌患者表皮生长因子受体基因突变检测中的比较
Cancer Res Treat. 2015 Oct;47(4):661-9. doi: 10.4143/crt.2014.282. Epub 2015 Feb 23.
7
Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.检测和比较肽核酸介导的实时聚合酶链反应夹心法和直接基因测序在非小细胞肺癌患者表皮生长因子受体突变中的应用。
Lung Cancer. 2012 Mar;75(3):321-5. doi: 10.1016/j.lungcan.2011.08.005. Epub 2011 Sep 17.
8
Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.鉴定恶性胸腔积液和脑脊液中具有激活 EGFR 突变的非小细胞肺癌:免疫细胞化学快速敏感检测外显子 19 缺失 E746-A750 和外显子 21 L858R 突变。
Lung Cancer. 2011 Oct;74(1):35-40. doi: 10.1016/j.lungcan.2011.02.002. Epub 2011 Mar 27.
9
Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.采用双重肽核酸夹介导的锁核酸-肽核酸 PCR 夹技术,对非小细胞肺癌患者血浆样本中的表皮生长因子受体突变进行超灵敏和定量检测。
Analyst. 2019 Feb 25;144(5):1718-1724. doi: 10.1039/c8an02446d.
10
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.通过快速灵敏的检测系统——肽核酸-锁核酸PCR钳揭示非小细胞肺癌细胞系中表皮生长因子受体的遗传异质性
Cancer Res. 2005 Aug 15;65(16):7276-82. doi: 10.1158/0008-5472.CAN-05-0331.

引用本文的文献

1
A bibliometric analysis of nucleic acid probe and its applications in oncology: towards more precise molecular medicine.核酸探针及其在肿瘤学中的应用的文献计量分析:迈向更精准的分子医学
Discov Oncol. 2025 May 8;16(1):702. doi: 10.1007/s12672-025-02478-3.
2
Localization of epidermal growth factor receptor-mutations using PNA:DNA probes in clinical specimens from patients with non-small cell lung cancer.使用肽核酸:DNA 探针在非小细胞肺癌患者临床标本中对表皮生长因子受体突变进行定位
Sci Rep. 2025 Apr 2;15(1):11314. doi: 10.1038/s41598-025-95081-z.
3
A Biotinylated cpFIT-PNA Platform for the Facile Detection of Drug Resistance to Artemisinin in .
一种生物素化的 cpFIT-PNA 平台,用于简便地检测. 中的青蒿素耐药性。
ACS Sens. 2024 Mar 22;9(3):1458-1464. doi: 10.1021/acssensors.3c02553. Epub 2024 Mar 6.
4
Localization of Mutations in Non-small-cell Lung Cancer Tissues Using Mutation-specific PNA-DNA Probes.使用突变特异性 PNA-DNA 探针定位非小细胞肺癌组织中的突变。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):375-382. doi: 10.21873/cgp.20389.
5
Explorations into Peptide Nucleic Acid Contrast Agents as Emerging Scaffolds for Breakthrough Solutions in Medical Imaging and Diagnosis.肽核酸造影剂作为医学成像与诊断突破性解决方案新兴支架的探索
ACS Omega. 2021 Oct 19;6(43):28455-28462. doi: 10.1021/acsomega.1c03994. eCollection 2021 Nov 2.
6
Analysis of Single Nucleotide-Mutated Single-Cancer Cells Using the Combined Technologies of Single-Cell Microarray Chips and Peptide Nucleic Acid-DNA Probes.利用单细胞微阵列芯片和肽核酸-DNA探针联合技术分析单核苷酸突变的单癌细胞
Micromachines (Basel). 2020 Jun 27;11(7):628. doi: 10.3390/mi11070628.